Israel Englander’s HilleVax HLVX Stock Holding History

Israel Englander’s Portfolio HLVX Stock Details HLVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-176,327	Closed	-$351K	–	6201
2025 Q2	$351K	Buy	176,327 +21,543	+14%	+$39.4K	﹤0.01%	5111
2025 Q1	$224K	Sell	154,784 -257,036	-62%	-$475K	﹤0.01%	5249
2024 Q4	$852K	Buy	411,820 +153,815	+60%	+$289K	﹤0.01%	4336
2024 Q3	$454K	Sell	258,005 -231,970	-47%	-$595K	﹤0.01%	4910
2024 Q2	$7.09M	Sell	489,975 -186,591	-28%	-$2.56M	﹤0.01%	2384
2024 Q1	$11.3M	Buy	+676,566	New	+$10.8M	﹤0.01%	2074
2022 Q3	–	Sell	-16,949	Closed	-$185K	–	7230
2022 Q2	$185K	Buy	+16,949	New	+$201K	﹤0.01%	5674

Israel Englander's HLVX Position: Q3 2025 in Review

Israel Englander sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 176,327 shares — an estimated $351K sold.

Israel Englander first reported a position in HLVX in Q2 2022 and held it in 7 quarters. The position peaked at $11.3M in Q1 2024. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

Israel Englander reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
Israel Englander sold 176,327 HilleVax shares in Q3 2025, an estimated $351K.
Israel Englander first reported a position in HilleVax in Q2 2022 and held it in 7 quarters.
Israel Englander's HilleVax position peaked at $11.3M in Q1 2024.
1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.